This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 May;8(5):243.

doi: 10.1038/nrcardio.2011.41. Epub 2011 Mar 15.

Hypertension: new meta-analysis shows no cancer risk with angiotensin-receptor blockers

Bryony M Mearns

PMID: 21451473
DOI: 10.1038/nrcardio.2011.41

Comment

Hypertension: new meta-analysis shows no cancer risk with angiotensin-receptor blockers

Bryony M Mearns. Nat Rev Cardiol. 2011 May.

. 2011 May;8(5):243.

doi: 10.1038/nrcardio.2011.41. Epub 2011 Mar 15.

Author

Bryony M Mearns

PMID: 21451473
DOI: 10.1038/nrcardio.2011.41

No abstract available

PubMed Disclaimer

Comment on

Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals.
ARB Trialists Collaboration. ARB Trialists Collaboration. J Hypertens. 2011 Apr;29(4):623-35. doi: 10.1097/HJH.0b013e328344a7de. J Hypertens. 2011. PMID: 21358417 Review.

References

1. J Hypertens. 2011 Apr;29(4):623-35 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.